Translation of "Type A inclusion body " (English → French) :

Lipschutz bodies [ Cowdry type A inclusion body | type A inclusion body ]

generalized inclusion body necrosis | generalized inclusion necrosis

inclusion body conjunctivitis | inclusion conjunctivitis

inclusion body encephalitis | inclusion encephalitis

Hereditary inclusion body myopathy type 4

Hereditary inclusion body myopathy type 3

Inclusion body myopathy type 3

Dawson's inclusion body encephalitis Van Bogaert's sclerosing leukoencephalopathy

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, a ...[+++]nalysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

bilateral involvement of limbs of the same body region injuries by type involving two or more body regions classifiable within S00-S99

2. if the fuel’s type is set out in column 1 of the applicable table to Schedule 5, its default CO emission factor as set out in column 3 and, if that fuel’s type is not so set out, the default CO emission factor for that fuel’s type established by a body that is internationally recognized as being competent to establish default CO emission factors for fuels and a statement that indicates the name of the body, and

3. if the fuel’s type is set out in column 1 of the applicable table to Schedule 5, its default CO emission factor as set out in column 3 and, if that fuel’s type is not so set out, the default CO emission factor for that fuel’s type established by a body that is internationally recognized as being competent to establish default CO emission factors for fuels and a statement that indicates the name of the body;

Mr. Speaker, the following question will be answered today: Question No. 24. Question No. 24 Mr. Peter Stoffer: With regard to Correctional Service of Canada (CSC): (a) how many adults serving custody sentences in the federal correctional system previously served in the Canadian Forces (CF) and RCMP from 2001 to 2013 inclusive; (b) how many of these adults specified above served their custody sentence in (i) federal minimum security prisons, (ii) federal medium security prisons, (iii) federal maximum security prisons; (c) how many ...[+++]offenders on conditional release previously served in the Canadian Forces and RCMP from 2001 to 2013 inclusive; (d) what is a breakdown on the types of offences committed by adults with previous service in the CF and RCMP for those serving custody sentences in federal correctional facilities and offenders on conditional release from 2001 to 2013 inclusive; (e) has CSC determined a re-conviction rate for adults who previously served in the CF or RCMP from 2001 to 2013 inclusive; (f) what is a breakdown of the types of rehabilitative needs adults who previously served in the CF and RCMP accessed while serving their custody sentence or conditional release (including psychological, social, or occupational training opportunities) from 2001 to 2013 inclusive; and (g) how many adults serving their custody sentence or conditional release with prior CF or RCMP service were treated for Post-traumatic Stress Disorder or Operational Stress Injuries from 2001 to 2013 inclusive?

Notified bodies in charge of product assessment (1) should, in addition to the steps foreseen in Sections 1, 2 and 3, sample devices belonging to at least three different device types and, where the manufacturer produces more than 99 device types, devices belonging to at least every hundredth type at the end of the production chain or in the manufacturer’s warehouse with a view of testing the conformity of the device types.